cbdMD, Inc. (YCBD)
NYSEAMERICAN: YCBD · Real-Time Price · USD
1.040
+0.269 (34.89%)
Jan 30, 2026, 4:00 PM EST - Market closed
cbdMD Revenue
In the fiscal year ending September 30, 2025, cbdMD had annual revenue of $19.19M, down -1.50%. cbdMD had revenue of $4.72M in the quarter ending September 30, 2025, with 3.61% growth.
Revenue (ttm)
$19.19M
Revenue Growth
-1.50%
P/S Ratio
0.22
Revenue / Employee
$456,916
Employees
42
Market Cap
10.91M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2025 | 19.19M | -291.70K | -1.50% |
| Sep 30, 2024 | 19.48M | -4.67M | -19.35% |
| Sep 30, 2023 | 24.16M | -11.25M | -31.77% |
| Sep 30, 2022 | 35.40M | -9.08M | -20.41% |
| Sep 30, 2021 | 44.48M | 2.60M | 6.20% |
| Sep 30, 2020 | 41.88M | 18.23M | 77.09% |
| Sep 30, 2019 | 23.65M | 23.19M | 5,051.82% |
| Sep 30, 2018 | 459.09K | -4.02M | -89.74% |
| Sep 30, 2017 | 4.47M | 2.44M | 120.27% |
| Sep 30, 2016 | 2.03M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Aytu BioPharma | 63.70M |
| IM Cannabis | 37.61M |
| Sunshine Biopharma | 37.32M |
| Biofrontera | 37.16M |
| Sonoma Pharmaceuticals | 16.94M |
| RedHill Biopharma | 9.55M |
| China Pharma Holdings | 4.05M |
| TherapeuticsMD | 2.80M |
YCBD News
- 2 days ago - cbdMD Strengthens Regulatory Science Platform to Support Emerging Regulatory Cannabinoid Evaluation Pathways - PRNewsWire
- 17 days ago - cbdMD Announces Strategic Acquisition of Bluebird Botanicals - PRNewsWire
- 6 weeks ago - cbdMD, Inc. (YCBD) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - cbdMD Reports Third Consecutive Year of Operating Improvement, Strengthens Balance Sheet, and Regains NYSE American Continued Listing Compliance - PRNewsWire
- 6 weeks ago - cbdMD, Inc. Announces Closing of $2.25 Million Series C Preferred Stock Private Placement - PRNewsWire
- 6 weeks ago - cbdMD, Inc. to Host Conference Call to Discuss September 30, 2025, Fourth Quarter and Fiscal Year 2025 Results - PRNewsWire
- 7 weeks ago - cbdMD, Inc. Regains Compliance with NYSE American Listing Standards - PRNewsWire
- 2 months ago - cbdMD Reports Preliminary Unaudited Fourth Quarter and Fiscal 2025 Results - PRNewsWire